Wunderlich Capital Managemnt Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$1.36M |
| 2 |
GSK
GSK
|
+$1.32M |
| 3 |
Pfizer
PFE
|
+$1.29M |
| 4 |
Whirlpool
WHR
|
+$1.21M |
| 5 |
Trane Technologies
TT
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.12M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$1.1M |
| 3 |
AGN
Allergan plc
AGN
|
+$1.03M |
| 4 |
Cummins
CMI
|
+$963K |
| 5 |
EOG Resources
EOG
|
+$958K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.93% |
| 2 | Healthcare | 10.98% |
| 3 | Industrials | 9.84% |
| 4 | Technology | 9.38% |
| 5 | Communication Services | 8.97% |
Similar funds
Wunderlich Capital Managemnt's Q4 2015 Portfolio in Review
As of Q4 2015, Wunderlich Capital Managemnt held 101 positions worth $116M, up 7.6% from $108M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wunderlich Capital Managemnt deployed $3.98M of net new capital in Q4 2015, opening 15 new positions and adding to 62 existing holdings. Its largest new stake was HCA Healthcare: 19,537 shares worth $1.32M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was iShares MSCI Japan ETF, an estimated $351K trimmed.
- Wunderlich Capital Managemnt's largest Q4 2015 buy was HCA Healthcare: 19,537 shares worth $1.32M.
- Wunderlich Capital Managemnt added most to International Paper in Q4 2015, an estimated $298K increase.
- Wunderlich Capital Managemnt's biggest Q4 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $351K.
- Wunderlich Capital Managemnt fully exited Biogen in Q4 2015, selling an estimated $1.12M.
- Wunderlich Capital Managemnt's ten largest holdings make up 24% of its $116M portfolio in Q4 2015.
- Wunderlich Capital Managemnt opened 15 new positions and closed 9 in Q4 2015.
- Wunderlich Capital Managemnt's portfolio value rose 7.6% quarter-over-quarter to $116M.
Based on Wunderlich Capital Managemnt's 13F filing for Q4 2015, filed 16 Feb 2016.